Italy (IT)

Quantum physics in space (2022) Belenchia A, Carlesso M, Bayraktar Ö, Dequal D, Derkach I, Gasbarri G, Herr W, et al. Journal article, Review article Relational observables in asymptotically safe gravity (2022) Baldazzi A, Falls K, Ferrero R Journal article Hydrogen role in the valorization of integrated steelworks process off-gases through methane and methanol syntheses (2022) Matino I, Dettori S, Zaccara A, Petrucciani A, Iannino V, Colla V, Bampaou M, et al. Journal article Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment (2022) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Journal article Correlation engineering via nonlocal dissipation (2022) Seetharam K, Lerose A, Fazio R, Marino J Journal article Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2022) Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, et al. Journal article Cardiovascular risk in high-hazard occupations: The role of occupational cardiology (2022) Parsons IT, Nicol ED, Holdsworth D, Guettler N, Rienks R, Davos CH, Halle M, Parati G Journal article, Review article Tunable cryogenic terahertz cavity for strong light-matter coupling in complex materials (2022) Jarc G, Mathengattil SY, Giusti F, Barnaba M, Singh A, Montanaro A, Glerean F, et al. Journal article [Lu-177]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study (2022) Singh S, Pavel ME, Kunz PL, De Herder W, Herrmann K, D'Amelio AM, Santoro P, et al. Conference contribution Impact of a reduced dosing interval of lanreotide autogel (LAN) on tumor growth rate (TGR) in patients with progressive neuroendocrine tumors (NETs) in the prospective, single-arm, phase 2 CLARINET FORTE trial (2022) Dromain C, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Capdevila J, et al. Conference contribution